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Background. To test whether receiving care from a health visitor (HV) trained in identiﬁcation and psychological
intervention methods prevents depression 6–18 months postnatally in women who are not depressed 6 weeks
postnatally.
Method. The study was a prospective cluster trial, randomized by GP practice, with follow-up for 18 months in 101
primary care teams in the Trent area of England. The participants were women scoring <12 on the postal Edinburgh
Postnatal Depression Scale (EPDS) at 6 weeks postnatally (1474 intervention and 767 control women). Intervention
HVs (n=89, 63 clusters) were trained in identifying depressive symptoms using the EPDS and face-to-face clinical
assessment and in providing psychologically orientated sessions based on cognitive behavioral or person-centered
principles. The control group comprised HVs (n=49, 37 clusters) providing care as usual (CAU). The primary
outcome measure was the proportion of women scoring o12 on the EPDS at 6 months postnatally. Secondary
outcomes were mean EPDS score, Clinical Outcomes in Routine Evaluation – Outcome Measure (CORE-OM) score,
State–Trait Anxiety Inventory (STAI), 12-item Short Form Health Survey (SF-12) and Parenting Stress Index Short
Form (PSI-SF) scores at 6, 12 and 18 months.
Results. After adjusting for individual-level covariates, living alone, previous postnatal depression (PND), the
presence of one or more adverse life events and the 6-week EPDS score, the odds ratio (OR) for EPDS o12 at 6
months was 0.71 [95% conﬁdence interval (CI) 0.53–0.97, p=0.031] for the intervention group (IG) women compared
with the control (CAU) group women. Two subgroups were formed by baseline severity: a ‘subthreshold’ subgroup
with a 6-week EPDS score of 6–11 (n=999) and a ‘lowest severity’ subgroup with a 6-week EPDS score of 0–5
(n=1242). There was no diﬀerence in psychological eﬀectiveness by subgroup (interaction term: z=x0.28, p=0.782).
Conclusions. This study provides new evidence of a universal, enduring preventive eﬀect for depression in women
who screen negative for depression postnatally.
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Introduction
The need for eﬀective population-wide prevention
approaches to depression, including mixed depression
and anxiety (Tyrer, 2001; Das-Munshi et al. 2008),
has been highlighted by the demonstration of un-
diminished population prevalence rates despite at
least a twofold increase in the usage of evidence-based
treatments (Brugha et al. 2004; Kessler et al. 2005).
Evidence of prevention of depression has not been
reported in a trial in adults but may be feasible;
in a recent meta-analysis synthesizing the results of
19 small prevention trials (Cuijpers et al. 2008), the
mean incidence rate ratio (IRR) of developing a de-
pressive disorder (including postpartum depression)
was 0.78 [95% conﬁdence interval (CI) 0.65–0.93], in-
dicating a reduction of the incidence by 22% in ex-
perimental compared to control groups.
Prevention can be considered as avoiding future
illness in those already at risk although disease free
or, more strictly, as avoiding future illness for all the
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ORIGINAL ARTICLEpopulation, not just those at immediate risk (Rose,
2001), hence the term universal prevention (Gordon,
1983; Mrazek & Haggerty, 1994). But how might
this be achieved? A highly signiﬁcant predictor
of depression within adulthood is ‘subthreshold’ de-
pression (Judd et al. 2002; Cuijpers & Smit, 2004).
Depression prevention through the extension of cog-
nitive behavioral therapy (CBT) to at-risk adolescents
who had symptoms that fell short of the threshold for
case depression (Clarke et al. 2001; Garber et al. 2009)
may be eﬀective because subthreshold levels are
highly predictive of depression (Cuijpers et al. 2005).
It is not known whether such skilful psychological
approaches could also beneﬁt a much wider range of
people at risk of developing depression if delivered
universally across an entire population to adults at all
risk levels.
In the UK all infants and all mothers, following
childbirth, receive individual care from a specialist
community nurse, known as a ‘Health Visitor’ (HV).
In addition to supporting infant care, the HV has a role
in maternal mental health that should involve estab-
lishing a relationship with the mother and the use of
interpersonal and communication skills (Morrell et al.
2009b). However, such practitioners are given little
more than basic mental health knowledge. Could
training HVs in psychological skills beneﬁt women
under their care who were not at immediate risk?
In this paper we report on the beneﬁts for all non-
depressed postnatal women randomized to receive
support from primary care nurses with specialized
training in psychologically informed approaches to
health care, in a large pragmatic cluster randomized
controlled and economic evaluation trial.
We have already reported on postnatal women in
randomly allocated intervention group (IG) clusters
cared for by an HV who had received additional
training in postnatal mental health assessment and in
one of two psychologically informed approaches that
were compared to usual HV care (Morrell et al. 2009a).
Clinical assessment and psychologically informed
approaches were designed to be oﬀered by inter-
vention group HVs to women scoring positive on
the Edinburgh Postnatal Depression Scale (EPDS)
(Morrell et al. 2009b) at 8 weeks following childbirth.
The EPDS is a widely used self-report measure to
identify women at risk of postnatal depression (PND)
with good evidence of sensitivity and speciﬁcity
(Gibson et al. 2009; Hewitt et al. 2009) and a score
ranging from 0 to 30, consisting of eight depression
and two anxiety items. We compared IG care with
postnatal care as usual (CAU). We showed that these
scoring positive IG women were less likely than CAU
women to have later depression, indicated by scoring
o12 on a postal EPDS at 6 months postnatally [odds
ratio (OR) 0.62, 95% CI 0.04–0.97, unadjusted p=0.036]
(Morrell et al. 2009a).
The trial was also designed to assess eﬀectiveness
according to severity of depression at baseline (www.
controlled-trials.com/ISRCTN92195776). Because out-
come data were obtained on all randomized and
consenting women, we were able to estimate any ef-
fects on women with baseline symptom scores below
the 6 weeks postnatal EPDS threshold of o12 (Cox
et al. 1987). Thus, the present paper reports new, un-
published analyses of outcomes from the original
treatment trial, principally for women who scored
<12 on the postal EPDS at 6 weeks postnatally, using
the same trial primary outcome: EPDS o12 at
6 months. First, eﬀects on outcomes at 6, 12 and 18
months postnatally were examined for women with
an EPDS<12 at 6 weeks. Second, to test whether
additional training of HVs was of beneﬁt to women
across a lower range of EPDS-negative scores, we
compared the eﬀectiveness in women at the lowest
EPDS severity levels (EPDS<6 at 6 weeks) with sub-
threshold scoring women (6-week EPDS scores from
6 to 11). Third, we examined diﬀerences in HV care,
including the use of randomly allocated face-to-face
administered depression assessment, because such
additional practitioner involvement could explain any
observed eﬀect on later risk of depression.
Method
The main pragmatic cluster randomized trial design
and methods, on which the present analysis is based,
are reported in detail elsewhere (Morrell et al. 2009a).
The present study involved assessing outcomes for
women in 101 primary care practices (clusters) (in one
region of England, serving a population of 5.1 million),
termed ‘EPDS-negative’, who had a postal EPDS score
<12 at 6 weeks postnatally. Following recruitment of
participating practices, an independent statistician
generated the random allocation sequence using a
computer randomization program (Morrell et al.
2009a). Thus, HVs registered to consenting practices
were randomized either to continue to provide post-
natal CAU or to an experimental IG in which all HVs
received additional training in systematic assessment
of depressive symptoms, establishing warm, thera-
peutic relationships, and in one of two distinct ex-
perimental psychologically informed approaches.
Eligible antenatal women were then recruited if they
were registered with participating (and therefore
randomized) GP practices, aged o18 years and had no
severe or enduring mental health problems. HVs were
asked to send these women a research information
leaﬂet and a consent form at 36 weeks of pregnancy or
4 weeks antenatally. Women returned their signed
740 T. S. Brugha et al.forms to the HVs. Altogether, 4084 (53.4%) of 7649
eligible antenatal women provided written informed
consent during 2003–2004. Consenting women were
sent a questionnaire at 6 weeks and 6, 12 and 18
months postnatally from the research oﬃce. Women
who scored o12 on their 6-week postal EPDS were
regarded as EPDS positive (n=595 women in 86
clusters) and were excluded from all of the present
outcomes analyses. Half of all women in the inter-
vention clusters (including EPDS-negative women)
were randomly allocated to complete a face-to-face
EPDS 6 weeks postnatally to coincide with usual HV
care during an existing HV contact. The intervention
cluster HVs, if their clinical assessment indicated that
any mother might beneﬁt, could also oﬀer the psycho-
logically informed sessions to which their practice had
been randomized.
Identical to the treatment trial protocol (Morrell
et al. 2009b), the pretrial determined primary outcome
was the proportion of women scoring o12 on the
EPDS at 6 months postnatally. We assumed an intra-
cluster coeﬃcient (ICC) of 0.006 (Morrell et al. 2009b)
and an average cluster of practice size of 25 EPDS-
negative women. Thus, 2489 women (1659 IG and 830
CAU) were required to have 80% power at the 5%
two-sided level of signiﬁcance, to detect a 3.5%
absolute diﬀerence (10% v. 6.5%) in the proportions of
6-week EPDS-negative IG and CAU women scoring
o12 on the EPDS at 6 months postnatally. Clusters
were allocated for the trial to one of two HV psycho-
logically based approaches (experimental IG) or HV
CAU, in a ratio of 1:1:1. The clusters were stratiﬁed by
the number of expected births per cluster per year,
into three groups (<70, 70–100, >100).
The cluster level intervention comprised the pack-
age of HV training in assessment of postnatal women
and identiﬁcation of depressive symptoms using the
EPDS and additional clinical assessment skills and
establishing warm, therapeutic relationships. They
were trained to deliver one of two distinct psycho-
logically informed approaches [a cognitive-behavioral
approach (CBA) and a person-centered approach
(PCA)], delivered at the individual level, with the
provision of additional supervisory support for the
HVs (Morrell et al. 2009b). The HV-provided psycho-
logically informed session was a one-hour visit, once a
week, for a maximum of 8 weeks, commencing around
8 weeks postnatally. Sessions were oﬀered to women
who scored o12 on the postal EPDS at 6 weeks and
also on a face-to-face EPDS administered at 8 weeks
postnatally.
IG HVs received a day of training in the identi-
ﬁcation of depression using the EPDS and clinical
assessment. The group training in the pretrial pre-
paratory phase lasted 8 days in total (including four
half-days), focusing on the development of cognitive
behavioral or person-centered intervention skills de-
livered in a group training format. A common element
of the training, preceding speciﬁc approach-based
skills, concerned development of empathic relation-
ships. The training package was followed by two
half-day reﬂective practice sessions and access to
regular supervision sessions. Two experienced
psychotherapist practitioner trainers delivered the
training, which followed a prepared manualized form
and was agreed by a training reference group com-
posed of experienced psychotherapy trainers. HVs
were asked to tape record their intervention sessions
(with the women’s consent) so that session treatment
ﬁdelity could be checked. From the recorded sessions
available it was clear that high levels of adherence
were achieved. HVs and women were also asked to
complete the Agnew Relationship Measure to measure
the therapeutic relationship between them. Further
details of the training are available in Morrell et al.
(2009b) and in ﬁndings to be reported separately.
HVs were blind to all research outcomes. Secondary
outcomes were measured in all women who were
followed up at 6, 12 and 18 months postnatally by
postal questionnaires (including the EPDS at 6 and
12 months only). These included the 12-item Short
Form Health Survey (SF-12) and the SF-6D (Ware et al.
1995), the Clinical Outcomes in Routine Evaluation –
Outcome Measure (CORE-OM) scales (Barkham et al.
2001) and the State–Trait Anxiety Inventory (STAI;
Spielberger et al. 1970). We used the CORE-OM as a
measure of global distress as used by psychological
therapy services to distinguish between clinical
and general populations. We measured postnatal
anxiety symptoms using the STAI (Spielberger et al.
1970). To achieve the required sample size for the
6-month primary outcome, the recruitment phase
was extended. However, the follow-up phase was
not similarly extended; therefore, all the women for
whom a 6-month outcome was available did not have
a baby who was 1 year or 18 months old within the
follow-up phase. Therefore, fewer questionnaires
were administered at these time points. We requested
funds to extend the recruitment phase but none were
provided.
Ethical approval was received from Trent Region
Multi-centre Research Ethics Committee.
Statistical analysis
The primary comparison reported for this analysis
was between eligible women in randomized IG prac-
tices versus those in CAU randomized practices, with
an EPDS score <12 at 6 weeks postnatally in addition
to a valid 6-month EPDS outcome score (n=2241
Universal prevention of depression 741EPDS-negative women in 101 clusters). All analyses
were by intention to treat with a p value <0.05
regarded as statistically signiﬁcant. A marginal gen-
eralized linear model (GLM), with coeﬃcients esti-
mated using generalized estimating equations (GEEs),
with robust standard errors and an exchangeable
autocorrelation matrix in Stata version 11 (StataCorp,
2009) was used to analyze outcomes and allow for the
clustered nature of the data, with associated 95% CIs.
We ﬁtted simple unadjusted models, and also adjusted
outcome comparisons for individual level covariates:
living alone, history of PND, presence of stressful life
events (Brugha et al. 1985) and 6-week EPDS score,
as the most widely identiﬁed signiﬁcant predictors
of PND (O’Hara & Swain, 1996). To test whether any
intervention eﬀect was conﬁned to those scoring im-
mediately below the EPDS scoring cut-oﬀ only, we
performed an intervention by baseline (6-week) EPDS
score statistical interaction test. This compared women
grouped to baseline EPDS scores of 6–11 with women
with a baseline EPDS score <6. We compared
6-month outcomes according to whether women were
in practices randomized for HVs to provide a face-
to-face assessment at 6 weeks plus postal assessment
compared to postal EPDS only. Evidence for dimin-
ished and diﬀerential health beneﬁt over time, be-
tween the groups, was tested for in a longitudinal
model by looking for evidence of an IG by time inter-
action. Thus, longitudinal modeling of 6, 12 and
18 months secondary outcomes, also using a marginal
GLM with coeﬃcients estimated by GEEs, was per-
formed to examine time eﬀects, group diﬀerences and
possible time by group interactions on the secondary
outcomes. The longitudinal models adjust for cluster-
ing of individual responses over time and not by
practice. For the primary outcomes, the binary EPDS
scores at 6 and 12 months, we used the multiple im-
putation procedure in STATA version 11 (StataCorp,
2009) to impute missing EPDS outcomes based on 100
imputations using a logistic regression model with
6-week EPDS score, lives alone, history of PND and
life events as predictors. The trial is reported ac-
cording to the CONSORT guidelines for cluster trials
(Campbell et al. 2004).
Results
Figure 1 shows the trial proﬁle. The 6-week question-
naire return rate was 83.7% (3419/4084), of whom
17.4% of women (595/3419) had an EPDS score of
o12 and 82.6% (2824/3419) were EPDS-negative. At
6 months, 79.4% (2241/2824) of the EPDS-negative
women had returned both 6-week and 6-month ques-
tionnaires, 767 in the control (CAU) group and 1474
in the IG. Table 1 shows the baseline and 6-week
characteristics of these 2241 new mothers. The
observed ICC for the primary outcome, the proportion
of women with an EPDS score of o12 at 6 months,
in the 100 clusters was 0.001 (95% CI 0.000–0.015).
As reported previously (Morrell et al. 2009a),
Table 2 shows that, at 6 months following childbirth,
83 out of 767 (10.8%) control (CAU) women and 113
of 1474 IG women (7.7%) scored o12 on the EPDS
at 6 months, that is an absolute diﬀerence of 3.1%
(95% CI 0.4–5.5) or a relative diﬀerence of 0.68 (95% CI
0.50–0.93, p=0.016). Of the covariates (living alone,
previous PND, presence of adverse life events in the
past 6 months and 6-week EPDS score), only living
alone was not a signiﬁcant predictor of the EPDS at
6 months. After adjusting for individual-level covari-
ates, the OR for a score of o12 at 6 months was 0.71
(95% CI, 0.53–0.97, p=0.031) for IG women compared
with CAU women. Multiple imputation computing
for missing 6-month EPDS scores increased the sample
size from 2241 to 2786, and the OR using the imputed
data, with adjustment for covariates, was similar to the
observed data (0.76, 95% CI 0.56–1.03, p=0.073).
The EPDS-negative women were divided into
two subgroups: a ‘subthreshold’ subgroup scoring
between 6 and 11 on the 6-week EPDS (n=999) and a
‘lowest severity’ subgroup scoring 0–5 on the 6-week
EPDS (n=1242) based on the approximate median
score for the sample. The choice of a cut-point between
5 and 6 on the EPDS was supported by the ﬁnding
that 55% (1242/2241) of EPDS-negative women scored
0–5. Those in the subthreshold subgroup (score 6–11)
did not beneﬁt signiﬁcantly more from IG member-
ship as deﬁned by the 6-week EPDS score (0–5, com-
pared to 6–11); a signiﬁcant intervention by subgroup
interaction was not found (z=x0.28, p=0.782)
(Table 2). The ORs for the eﬀect of HV training in these
two EPDS score subgroups scarcely diﬀered (0.76 and
0.69 respectively; Table 2). The results of a similar
comparison of low- and high-risk women also show-
ing no diﬀerence in eﬀectiveness are available on
request.
Among the secondary outcomes of this study, at
6 months the mean EPDS score in EPDS-negative
women was 5.4 (S.D=4.5) for CAU women and 4.8
(S.D=4.2) for IG women, a diﬀerence of x0.6 (95%
CI x0.9 to x0.1, p=0.007), which was statistically
signiﬁcant (p=0.007). This diﬀerence remained stat-
istically signiﬁcant after adjusting for the same 6-week
and baseline covariates (p=0.013) (Table 3). A signiﬁ-
cant diﬀerence (p=0.020) in the 6-month CORE-OM
total score favoring the IG women (mean=0.38) over
CAU women at 6 months was also found (mean=
0.43) with other outcome comparisons (SF-12 and State
Anxiety) being not signiﬁcant. A comparison of out-
comes for IG women in the two randomly allocated
742 T. S. Brugha et al.training groups (CBA or PCA) also showed no
diﬀerence in eﬀectiveness: compared to the control
(CAU) EPDS score, at 6 months the mean EPDS score
in the CBA group was 4.7 (n=708, S.D=4.2); and in the
PCA group it was 4.9 (n=766, S.D=4.3).
EPDS-negative women in the face-to-face clinical
assessment group (n=746) had a lower mean EPDS
score at 6 months than women who only received
a postal EPDS (n=728; diﬀerence 0.68, 95% CI
0.25–1.20, p=0.002); this was of borderline statistical
signiﬁcance following adjustment (p=0.054). When
comparing the binary 6-month EPDS outcomes (EPDS
score o12), the diﬀerences were not statistically sig-
niﬁcant (unadjusted p=0.126; adjusted p=0.301).
Because of trial funding limitations, fewer postal
questionnaires were sent to women and thus returned
at 12 and 18 months (n=807) than at 6 months
(n=2659). In addition to the 6-week and 6-month re-
turns, 1450 women also completed and returned a
postal follow-up at 12 months and 806 at 18 months.
At the 12-month follow-up, 9.6% (48/499) of women
in the CAU group and 6.8% (65/951) of women in the
IG had an EPDS score o12 and an unadjusted OR
of 0.68 (95% CI 0.44–1.05, p=0.079). After adjusting
for covariates, the OR was 0.74 (95% CI 0.48–1.14,
p=0.167). Using a multiple imputation method for
computing missing 12-month EPDS scores increased
the sample size from 1450 to 2786, and the OR using
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4084 women
1335 women consented.  2749 women consented.
↓ ↓↓ ↓
Six-Week Follow-up
100 Clusters 
3419 women 
2824 'EPDS-
negative women'
37 Clusters.
1 Cluster lost to follow-up. 
1151/1335 (86.2%) returned a 6-W questionnaire. 
191/1151 (16.6%) scored ≥12 on 6-W EPDS. 
960/1151 (83.4%) scored <12 on 6-W EPDS.
63 Clusters.
2268/2749 (82.5%) returned a 6-W questionnaire. 
404/2268 (17.8%) scored ≥12 on 6-W EPDS. 
1864/2268 (82.2%) scored <12 on 6-W EPDS.
↓ ↓↓ ↓
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up  
100 Clusters  
2871 women 
2471 EPDS-
negative women  
37 Clusters.
994/1335 (74.5%) returned 6-M questionnaire.
166/994 (16.7%) scored ≥12 on 6-M EPDS. 
828/994 (83.3%) scored <12 on 6-M EPDS.
63 Clusters.
1877/2749 (68.2%) returned 6-M questionnaire.
234/1877 (12.5%) scored ≥12 on 6-M EPDS. 
1643/1877 (87.5%) scored <12 on 6-M EPDS.
↓ ↓↓ ↓
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37 Clusters provided data for ‘EPDS-negative’ analysis.
914/1335 (68.5%) women provided 6-W and 6-M EPDS 
data for analysis. 
Of these 767/914 (83.9%) women scored <12 on 6-W 
EPDS and provided data for ‘EPDS negative women’ 
analysis in 37 Clusters. 
63 Clusters provided data for ‘EPDS-negative’ analysis.
1745/2749 (63.5%) women provided 6-W and 6-M EPDS data 
for analysis. 
Of these 1474/1745 (84.5%) women scored <12 on 6-W 
EPDS and provided data for ‘EPDS-negative’ women analysis 
in 63 Clusters. 
Provided 12-Month 
Data for  
‘EPDS-negative’ 
Analysis: 99 
Clusters and 1450 
‘EPDS-negative’ 
women 
37 Clusters provided data for ‘EPDS-negative’ analysis. 
499/767 (65.0%) ‘EPDS-negative’ women provided 12-M 
EPDS data for analysis in 37 Clusters.  
451/499 (90.4%) ‘EPDS-negative’ women scored <12 on 
12-M EPDS. 
62 Clusters provided data for ‘EPDS negative’ analysis.
1 Cluster lost patients to 12-month follow-up. 
951/1474 (64.5%) ‘EPDS-negative’ women provided  
12-M EPDS data for analysis in 62 Clusters. 
886/951 (93.2%) ‘EPDS-negative’ women scored <12 on  
12-M EPDS.
Fig. 1. Trial proﬁle of clusters and participants in the intervention group (IG) and the care as usual (CAU) group for all
women and Edinburgh Postnatal Depression Scale (EPDS) negative women.
Universal prevention of depression 743the imputed data, with adjustment for covariates, was
0.89 (95% CI 0.62–1.28).
Group eﬀects and time eﬀects were found for the
EPDS (continuous) outcome. However, after adjusting
for baseline covariates, no signiﬁcant group by time
statistical interactions were found on any of the out-
come measures [EPDS binary, EPDS continuous,
CORE-OM, SF-12 mental component summary scale
(MCS), SF-12 physical component summary scale
(PCS), State-Anxiety]. Group eﬀects, but not time ef-
fects, were found for the CORE-OM and EPDS binary
outcomes. A signiﬁcant time eﬀect only was observed
for the two SF-12 outcomes. No group or time eﬀects
were observed for the State Anxiety outcome.
Table 1. Baseline and 6 weeks characteristics of ‘EPDS-negative women’ by group
(n=2241)
Care as usual
(CAU)
(n=767)
Intervention
group (IG)
(n=1474)
Age (years), n (mean), S.D. 766 (32.2), 5.0 1474 (31.4), 5.0
Age when ﬁrst child born (years), n (mean), S.D. 744 (29.2), 5.2 1449 (28.2), 5.2
Number of other children, n (mean), S.D. 767 (0.7), 0.8 1474 (0.7), 0.8
EPDS score at 6 weeks, n (mean), S.D. 767 (5.2), 3.2 1474 (5.0), 3.1
SF-12 PCS score at 6 weeks, n (mean), S.D. 745 (50.9), 8.1 1454 (51.6), 7.7
SF-12 MCS score at 6 weeks, n (mean), S.D. 745 (45.3), 7.1 1454 (45.4), 7.0
CORE-OM score at 6 weeks, n (mean), S.D. 760 (0.4), 0.3 1466 (0.4), 0.3
Lives alone with child/ren, n (%)
No 735 (96.8) 1430 (97.3)
Yes 24 (3.2) 39 (2.7)
Total 759 (100.0) 1469 (100.0)
Previous history of PND, n (%)
No/ﬁrst child 709 (92.8) 1364 (92.7)
Yes 55 (7.2) 107 (7.3)
Total 764 (100.0) 1471 (100.0)
Previous history of major life events, n (%)
No 466 (61.2) 903 (61.6)
Yes 295 (38.8) 563 (38.4)
Total 761 (100.0) 1466 (100.0)
Number of other children, n (%)
0 370 (48.2) 661 (44.8)
1 305 (39.8) 601 (40.8)
2 71 (9.3) 166 (11.3)
3 13 (1.7) 33 (2.2)
4 5 (0.7) 3 (0.2)
5 3 (0.4) 10 (0.7)
Total 767 (100.0) 1474 (100.0)
Ethnicity, n (%)
Non-white 29 (3.8) 45 (3.1)
White 738 (96.2) 1429 (96.9)
Total 767 (100.0) 1474 (100.0)
English ﬁrst language, n (%)
No 26 (3.4) 41 (2.8)
Yes 741 (96.6) 1433 (97.2)
Total 767 (100.0) 1474 (100.0)
EPDS, Edinburgh Postnatal Depression Scale; SF-12, 12-item Short Form Health
Survey; PCS, physical component summary scale; MCS, mental component
summary scale; CORE-OM, Clinical Outcomes in Routine Evaluation – Outcome
Measure; PND, postnatal depression, S.D., standard deviation.
Better health is represented by a lower score in CORE-OM and EPDS and a
higher score in the SF-12 and SF-6D.
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Our analysis has shown that women who scored
below the EPDS threshold at 6 weeks after childbirth
were less likely to score above the EPDS threshold
at 6 months after childbirth if their HV had under-
gone training in identifying depressive symptoms,
developing therapeutic relationships and providing
psychological approaches to managing depression.
Furthermore, this eﬀect applied equally across women
at all initial levels of risk, not just those close to the
above threshold, thus suggesting a universal eﬀect.
This eﬀect did not diminish over later assessments at
12 and 18 months following childbirth. How plausible
is this eﬀect and can it be explained?
We found that the training was eﬀective in the sep-
arately reported treatment trial in EPDS positive
(EPDS score o12) women (Morrell et al. 2009a),
although 61% agreed to, and only 28% of all EPDS
positive IG women providing outcome data had
completed, HV sessions. In the present study, ap-
proximately 1% of IG EPDS-negative women were
oﬀered and completed at least one session. So we need
to ask why and how was HV training universally
eﬀective most notably in the EPDS-negative women?
Cross-contamination eﬀects are likely to have been
minimized by clustering HVs. One previous primary
care trial, using a similarly powered clustered design,
in which midwives were trained in a protocol to
focus on speciﬁc physical and mental health needs of
mothers after childbirth, also reported signiﬁcantly
lower EPDS scores at 4 months follow-up in women in
IG practices (MacArthur et al. 2002). However, there
were insuﬃcient baseline data available to identify
women with greater depression severity to determine
whether eﬀectiveness was conﬁned to a subgroup of
likely cases of depression or was preventive across the
whole range of baseline severity.
What seems to matter is the diﬀerence between
being registered with a practice that has adopted the
experimental versus the CAU policy. This involves
diﬀerences in practice environment and culture. More
speciﬁcally, receiving training and developing the skill
to assess mental health and provide psychologically
informed sessions is likely to aﬀect the practitioners
themselves through increased conﬁdence. It creates a
focus of care on the mother’s psychological well-being
and not just on the physical welfare of the child.
Women may beneﬁt from the HVs’ enhanced com-
munication skills and knowing that emotional issues
are open for discussion if needed, without the possibly
stigmatizing requirement to refer to a diﬀerent pro-
fession or service. We were able to show evidence in
the women who were below threshold at 6 weeks of a
positive eﬀect of being randomly assigned to receive a
face-to-face EPDS administration and clinical assess-
ment, when compared with a research oﬃce postally
administered EPDS questionnaire only. As reported
separately, empirical support for change in HV ac-
tivity was shown in the resource use logs of these
lower-risk women (Brugha et al. 2009). As the EPDS
score increased, in the IGs, a clear increase in the
Table 2. Primary outcome: proportion of EPDS-negative women with EPDS score o12
at 6 months, by intervention group (IG) or care as usual (CAU) group, comparing EPDS
subthreshold and lowest EPDS score subsamples deﬁned according to EPDS score at 6
weeks (n=2241)
EPDS score
at 6 weeks
6-month
EPDS score CAU n (%) IGn (%) ORIG/CAU*
95% CI
for OR
Lowest score <12 386 (94.8) 802 (96.0)
(EPDS f5) o12 21 (5.2) 33 (4.0) 0.76 0.42–1.36
407 (100.0) 835 (100.0)
Subthreshold <12 298 (82.8) 559 (87.5)
(5<EPDS<12) o12 62 (17.2) 80 (12.5%) 0.68 0.48–0.97
360 (100.0) 639 (100)
EPDS<12 <12 684 (89.2) 1361 (92.3)
o12 83 (10.8) 113 (7.7) 0.68 0.50–0.93
767 (100.0) 1474 (100.0)
EPDS, Edinburgh Postnatal Depression Scale; OR, odds ratio; CI, conﬁdence
interval.
p value for interaction term between lowest score (EPDS f5) and subthreshold
(5<EPDS<12) groups=0.782.
*p value for interaction term adjusted for lives alone (yes/no), history of postnatal
depression (PND) (yes/no), any life events (yes/no)=0.749.
Universal prevention of depression 745number of visits was seen (Brugha et al. 2009), which
seemed to be due to a greater recognition of the need
for professional input relating to PND by IG teams;
whereas concurrently, there were fewer visits by inter-
vention HVs relating to the mothers with lower EPDS
scores, presumably because visits are judged to be
unnecessary.
The question remains unanswered: how did inter-
vention cluster women beneﬁt without formal psycho-
logical therapy sessions? The purpose of training
was also to establish a high-quality, warm, therapeutic
relationship with the women (Morrell et al. 2009b).
Concepts of social support have been suggested to
explain the common underlying mechanisms in the
eﬀectiveness of cognitive behavioral, interpersonal
and other therapies (Brugha, 1995). Tailoring to need
and availability of support from a trained professional
could potentially inﬂuence perception of available
support, which may be the key parameter, rather than
objective support. The value of tailoring and ﬂexible
care has certainly been suggested by MacArthur et al.
(2002), but in that study women were provided care
from midwives and followed only to 4 months post-
natally.
Psychological interventions focusing on inter-
personal issues during pregnancy have also shown
some promise (Spinelli & Endicott, 2003; Zlotnick et al.
2006). This result contrasts with two previous in-
eﬀective prevention trials conducted in the same
population by the present authors (T.S.B., C.J.M.) that
employed external (research) therapists (Brugha et al.
2000; Morrell et al. 2000). Thus, individually delivered
psychosocial interventions by professionals may be
more eﬀective postnatally (Dennis, 2005) when in-
tegrated into routine visits. For example, one other
randomized trial of enhanced and personalized mid-
wife-managed care in the early postnatal period also
reported better EPDS outcomes at 7 weeks postnatally
(Shields et al. 1997). The similarity of both sets of re-
search ﬁndings runs counter to the suggestion that our
result is a chance, fortuitous ﬁnding.
Study limitations need to be considered given
the potential public health signiﬁcance of the results.
A potential limitation of the study is that the EPDS
subgroup by IG interaction tests have limited power
to detect anything other than large interactions
(Montgomery et al. 2003). The CI for the OR for the
interaction eﬀect at 6 months after adjustment for
covariates (0.44–1.87) was relatively wide, so we can-
not exclude such an eﬀect, although the point estimate
of the OR of 0.91 suggests this is unlikely. However,
the interaction was not of primary interest and the trial
was adequately powered to detect a reasonable target
intervention eﬀect, equivalent to an OR of 0.63. A full
clinical interview was not performed on all CAU and
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746 T. S. Brugha et al.IG EPDS-negative women and our primary outcome
was thus not clinically assessed depression caseness.
However, the EPDS is a well-established, reliable in-
dicator of likelihood of clinical depression (Gaynes
et al. 2005). Bias may arise with cluster randomization
because individual recruitment occurs after random-
ization (Puﬀer et al. 2005). According to Table 1, the
proﬁles of IG and CAU women were remarkably bal-
anced but, nevertheless, our analysis adjusted for key
predictors of depression outcome. A planned repli-
cation and extended generalization of ﬁndings will be
needed in other populations.
Rose (1992) argued that more people would beneﬁt
from a universal intervention. In our treatment trial
(Morrell et al. 2009b) we found that 31 (11.4%) of 271
EPDS positive women beneﬁted from intervention.
In this prevention analysis, in EPDS-negative women,
46 (3.1%) of 1474 women beneﬁted. Accordingly,
the new intervention policy beneﬁted far more
women in the prevention (EPDS-negative) than in
the treatment (EPDS positive) groups. Our ﬁnding
that mental health beneﬁts did not diminish over
18 months of follow-up contrasts with the short-term
eﬀectiveness of depression interventions in general
and may reﬂect the ongoing extended contact that
HVs often have with postnatal women. Additional
analyses from this trial showed the probability that the
intervention is cost-eﬀective at various ‘threshold
values’ of a quality-adjusted life year (QALY). In the
range of QALY values between £20000 and £30000,
the probability of the intervention being cost-eﬀective
is over 99% (Brugha et al. 2009). Thus, costs were
lower and outcomes better in IG compared to CAU
women, a concept often referred to by economists as
‘dominance’.
Until now, governments and policy makers have
held back from investing signiﬁcantly in depression
prevention programs, arguably because of lack of
convincing evidence for policy change and cost. To
date, there have been no large-scale trials testing
whether universal prevention eﬀects have occurred
across a whole population. There is now new evidence
for clinically signiﬁcant, useful and persistent reduc-
tions in the prevalence of depression in a key part of
the population, women following childbirth, which
requires further independent evaluation.
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